Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential


TSX:EDT - Post by User

Comment by mercedesmanon Jan 25, 2023 11:37am
143 Views
Post# 35245283

RE:RE:RE:RE:RE:RE:Great ... I think...

RE:RE:RE:RE:RE:RE:Great ... I think...
Rickkie wrote: Buy low, sell high, the mantra of the trader (investor?). Easier said than done, though,

MM, will you be kind enough to let us long time sufferers know when the end game is finally here so we  can get go along for the ride?


Very hard to do.

Especially admist alot of gaslighting.   You have to be prepared to contra the herd.

In any event, I'd say that the endgame is here now.   But they can be long drawn out affairs when the FDA is involved.  Especially when the winning side decides to take its sweet time pushing their advanatge (i.e moving their pawns down the board to be queened as a near final act preceeding the checkmate).

Be it an abundance of caution, strategic or some keystone coppery (or some combination)...I really don't think that the final outcome is in doubt.  Baxter's quasi-equity infusion (over and above Tigris Trial cost contributions) seems to confirm that...as does the FA80's November contribution (complete with anti-dilutionary warrants).

Worried about the "lifestyle" bleed?  Please!  That's so last year.  Plus Infomed has seemingly agreed to pick up the remaining tab on the US distribtuion infrastructure build-out and usabiilty study costs for DIMI (worth 20%?  that's still up for debate)

MM

<< Previous
Bullboard Posts
Next >>